These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36237446)

  • 1. The development of a novel antioxidant-based antiemetic drug to improve quality of life during anticancer therapy.
    Yanagawa H; Koyama Y; Kobayashi Y; Kobayashi H; Shimada S
    Biochem Biophys Rep; 2022 Dec; 32():101363. PubMed ID: 36237446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy agent cisplatin induces 48-h Fos expression in the brain of a vomiting species, the house musk shrew (Suncus murinus).
    De Jonghe BC; Horn CC
    Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R902-11. PubMed ID: 19225146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multi-drug antiemetic treatment and effect of treatment duration of concurrent steroids--for complete control of chemotherapy-induced nausea/vomiting in gynecological cancer].
    Fujii T; Nakata N; Shiroyama Y; Sawasaki T; Tanimoto H; Shigemasa K; Kioka H; Naito H
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2245-52. PubMed ID: 9422069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective review of antiemetic use for chemotherapy-induced nausea and vomiting in pediatric oncology patients at a tertiary care center.
    Aseeri M; Mukhtar A; Al Khansa S; Elimam N; Jastaniah W
    J Oncol Pharm Pract; 2013 Jun; 19(2):138-44. PubMed ID: 23034405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiemetic effects of granisetron and dexamethasone combination therapy during cisplatin-containing chemotherapy for head and neck cancer: dexamethasone dosage verification trial.
    Tsukuda M; Ishitoya J; Mikami Y; Matsuda H; Katori H; Horiuchi C; Kimura M; Taguchi T; Yoshida T; Nagao J; Sakuma Y; Toth G
    Int J Clin Oncol; 2009 Aug; 14(4):337-43. PubMed ID: 19705245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ondansetron. An update of its therapeutic use in chemotherapy-induced and postoperative nausea and vomiting.
    Markham A; Sorkin EM
    Drugs; 1993 Jun; 45(6):931-952. PubMed ID: 7691500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous metoclopramide: prevention of chemotherapy-induced nausea and vomiting. A preliminary evaluation.
    Strum SB; McDermed JE; Pileggi J; Riech LP; Whitaker H
    Cancer; 1984 Mar; 53(6):1432-9. PubMed ID: 6692333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy.
    Yarker YE; McTavish D
    Drugs; 1994 Nov; 48(5):761-93. PubMed ID: 7530631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of granisetron injection against nausea and vomiting induced by anticancer drugs including cisplatin].
    Yoshiya N; Kodama S; Tanaka K; Hataya I; Tokunaga A; Takeuchi Y; Hanaoka J; Yanase T; Takahashi T; Maruhashi T
    Gan To Kagaku Ryoho; 1994 Aug; 21(10):1641-6. PubMed ID: 8060140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of a combination of ondansetron, methylprednisolone and metopimazine in patients previously uncontrolled with a dual antiemetic treatment in cisplatin-based chemotherapy. The French Ondansetron Study Group.
    Lebeau B; Depierre A; Giovannini M; Rivière A; Kaluzinski L; Votan B; Hédouin M; d'Allens H
    Ann Oncol; 1997 Sep; 8(9):887-92. PubMed ID: 9358940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of clinical outcomes and efficacy of palonosetron and granisetron in combination with dexamethasone in Egyptian patients receiving highly emetogenic chemotherapy.
    A Mahrous M; A El-Azab G; A Tawfik H
    Cancer Chemother Pharmacol; 2021 Jul; 88(1):121-129. PubMed ID: 33835230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical effect of two azasetron treatment methods against nausea and vomiting induced by anticancer drugs including CDDP].
    Kimura E; Niimi S; Watanabe A; Tanaka T
    Gan To Kagaku Ryoho; 1997 May; 24(7):855-9. PubMed ID: 9170525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimum management of nausea and vomiting in cancer chemotherapy.
    Triozzi PL; Laszlo J
    Drugs; 1987 Jul; 34(1):136-49. PubMed ID: 3308410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a compassionate-use program using intravenous ondansetron to prevent nausea and vomiting in patients receiving emetogenic cancer chemotherapy.
    Berry WR; House KW; Lee JT; Plagge PB; Meshad MW; Grapski R
    Semin Oncol; 1992 Dec; 19(6 Suppl 15):33-7. PubMed ID: 1485180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood.
    Phillips RS; Gopaul S; Gibson F; Houghton E; Craig JV; Light K; Pizer B
    Cochrane Database Syst Rev; 2010 Sep; (9):CD007786. PubMed ID: 20824866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on clinical effect of a continuous intravenous infusion of azasetron against nausea and vomiting induced by anticancer drugs including CDDP].
    Kimura E; Niimi S; Watanabe A; Akiyama M; Tanaka T
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):477-81. PubMed ID: 8678501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta 9-tetrahydrocannabinol suppresses vomiting behavior and Fos expression in both acute and delayed phases of cisplatin-induced emesis in the least shrew.
    Ray AP; Griggs L; Darmani NA
    Behav Brain Res; 2009 Jan; 196(1):30-6. PubMed ID: 18721829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified olanzapine-based anti-emetic regimen for the control of nausea and vomiting in patients receiving weekly cisplatin.
    Mehra N; Christopher V; Dhanushkodi M; Radhakrishnan V; Ganesan TS; Ganesharajah S; Sagar TG; Ganesan P
    Int J Clin Pharm; 2020 Apr; 42(2):662-666. PubMed ID: 32152887
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.